Finally, the NGS analysis identified genomic amplification of the smoothened homolog (SMO) gene in a melanoma patient and thereby SMO inhibitors (sonidegib and vismodegib) were suggested as a treatment of choice for that cancer (13). Here, SMO is linked to cancer.